BioWorld MedTech

April 30, 2013

Deals roundup: Bayer to acquire Conceptus for $1.1B, via tender offer

Bayer Healthcare (Leverkusen, Germany) said it has signed a merger agreement with Conceptus (Mountain View, California), the developer of the Essure procedure, a non-surgical permanent birth control method, for $1.1 billion. Read More

CVRx obtains FDA nod to start Barostim neo hypertension study

Report from Europe: CircuLite gets final results on Synergy CE mark study

Washington roundup: Defibrillators, spinal fusion, radiotherapy win IPPS draft

Financings roundup: RainDance closes $20M Series E funding round

Court report: AirStrip, mVisum settle suit over physiological data

Agreements/contracts: GenomeDx Biosciences expands Mayo collaboration

Medical Device Daily presents a brand-new webinar

HIT roundup: Johns Hopkins to participate in PathCentral Pathology network

Med-Tech Notes

Product Briefs

People in the News

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for March 19, 2026.

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...